Ibrunitime 25 Tablet is used to treat rheumatoid arthritis. It works by improving abnormal immunological responses and suppressing the production of substances that cause redness and swelling.
Ibrunitime 25 Tablet can be taken with or without food. Take it regularly and do not stop taking the medicine even if you get better until that doctor tells you it is alright to stop. Drink an adequate amount of water while on treatment with this medicine, this will prevent you from getting kidney stones.
The most common side effects of this medicine include liver dysfunction, pneumonia, and upper abdominal pain. If any of these side effects persist or worsen, let yor doctor know. Your doctor may help with ways to reduce or prevent these symptoms by prescribing you an alternative medicine or by adjusting the dose.
To make sure the medicine is safe for you, let your doctor know if you have any problems with your heart, kidneys, or liver. You should also let your doctor know all the other medicines you are taking before using this medicine. If you are pregnant or breastfeeding, consult your doctor first before taking this medicine.
Ibrunitime 25 Tablet reduces pain, stiffness, and swelling in your joints and slows down the progression of bone and joint damage. This will help you do normal daily activities more easily and thus improve your quality of life. This medicine should be taken at the same time each day to get maximum benefits. Keep taking it even if you feel well because it is preventing future harm as well as improving your symptoms.
Side effects of Ibrunitime Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Ibrunitime
Liver dysfunction
Pneumonia
Upper abdominal pain
How to use Ibrunitime Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ibrunitime 25 Tablet may be taken with or without food, but it is better to take it at a fixed time.
How Ibrunitime Tablet works
Ibrunitime 25 Tablet is a disease-modifying anti-rheumatic drug (DMARD). It works by improving abnormal immunological response and suppressing the production of substances that cause inflammation (redness and swelling) in rheumatoid arthritis.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Ibrunitime 25 Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Information regarding the use of Ibrunitime 25 Tablet during pregnancy is not available. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Ibrunitime 25 Tablet during breastfeeding is not available. Please consult your doctor.
Driving
CONSULT YOUR DOCTOR
It is not known whether Ibrunitime 25 Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Ibrunitime 25 Tablet in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Ibrunitime 25 Tablet in patients with liver disease. Please consult your doctor.
What if you forget to take Ibrunitime Tablet?
If you miss a dose of Ibrunitime 25 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Ibrunitime 25 Tablet is prescribed for the treatment of rheumatoid arthritis.
If you take any medicines like painkillers such as ibuprofen, let your doctor know. This is because it might interfere with Ibrunitime 25 Tablet and may either stop it from working fully or might cause some side effects.
Inform your doctor if you have been told you have lupus erythematosus. This is also an autoimmune disease-causing inflammation.
Let your doctor know if you have any kidney problems.
Sir/Ma'am, I feel pain in the heel of both the legs especially when I get up from the bed in the morning. After walking couple of steps, it goes away. there is no bone problem reported in the Xray report. Please guide me what could be the reason?
Severe Joint pain in left hand wrist, elbow, shoulder and neck joint. Took some TEST and reports attached. Provided tablets are not killing the pain. Kindly help and guide us in right way. Attached Anti CCT TEST repory
Vipul Aggarwal
Looks like a case of rheumatoid arthritis.Kindly consult a rheumatologist asap
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
References
Ishikawa K, Ishikawa J. Iguratimod, a synthetic disease modifying anti-rheumatic drug inhibiting the activation of NF-κB and production of RANKL: Its efficacy, radiographic changes, safety and predictors over two years' treatment for Japanese rheumatoid arthritis patients. Mod Rheumatol. 2019;29(3):418-29. [Accessed 17 Feb. 2020] (online) Available from:
Li J, Mao H, Liang Y. Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis. Journal of Immunology Research. 2013 [online]. [Accessed 17 Feb. 2020] (online) Available from:
Mucke HA. Iguratimod: a new disease-modifying antirheumatic drug. Drugs Today (Barc). 2012;48(9):577-86. [Accessed 17 Feb. 2020] (online) Available from:
Xie S, Li S, Tian J, et al. Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape. Front Pharmacol. 2020;11:73. [Accessed 05 Jul. 2023]. (online) Available from:
Hara M, Abe T, Sugawara S, et al. Long-term safety study of iguratimod in patients with rheumatoid arthritis. Mod Rheumatol. 2007;17(1):10-6. [Accessed 05 Jul. 2023]. (online) Available from: